bemnifosbuvir.

Atea sticks it out with failed COVID-19 antiviral but also raids Merck's store room for hepatitis C drug
Fierce Biotech
Fri, 01/7/22 - 10:47 am
Atea Pharmaceuticals
antivirals
COVID-19
Merck
bemnifosbuvir.